Kanishk Kharbanda Appointed As Director Of International Business
ncarol.com/10122157

MORRISVILLE, N.C. - ncarol.com -- BioMedomics, Inc. has announced that Mr. Kanishk Kharbanda has been appointed as Director of International Business with immediate effect. In his new role, Mr. Kharbanda will be responsible for the success of all outside-US operations which include sales, marketing, regulatory, logistics and manufacturing strategy. He will also be responsible for driving sales in Asia Pacific and EU regions.

With over 17 years' experience in international healthcare business, Kanishk has proven himself a visionary leader, strategic thinker, with a stellar reputation in the industry. Prior to joining BioMedomics Kanishk worked in business strategy consulting, market access, and public health program management in top companies and non-profit foundations. Kanishk earned his Master's in Business degree from the renowned Duke University's Fuqua School of Business and Bachelor's in Engineering degree from Manipal Institute of Technology.

More on ncarol.com

• AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
• IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
• Are You Hiring The Right Heater Repair Company in Philly?
• Charlotte Becomes the Epicenter of HBCU Culture: The 2026 BIG HBCU Southern Classic Returns
• Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut

"We are extremely fortunate and honored to have Kanishk as part of our Leadership Team", said Brad Heidinger, COO of BioMedomics. "Kanishk has been a great asset to our company in his previous role and I know he will continue to be impactful as our Director of International Business. He has an unquestionable skill set and is a real leader that brings both innovation and expertise.  He adds tremendous depth and value to our company."

"With our rich product pipeline and growing international customer base, we're at an inflection point as a company." said Kharbanda. "This brings ample challenges and opportunities - to grow and to streamline in lock step while delivering best-in-class customer experiences. A balancing act we're going to take head on."

For more information about BioMedomics, visit http://www.biomedomics.com